| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $120.2M | -19.4% |
| Cost of Revenue | $1.7M | +61.5% |
| R&D Expense | $60.3M | -7.6% |
| SG&A Expense | $112.5M | +22.4% |
| Operating Income | -$55.5M | -344.5% |
| Interest Expense | $3.7M | -23.7% |
| Pre-tax Income | -$58.6M | -238.4% |
| Income Tax | $605K | +0.0% |
| Net Income | -$58.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.5M | +29.5% |
| Short-term Investments | $33.7M | -68.2% |
| Accounts Receivable | $40.3M | +160.6% |
| Inventory | $9.1M | +37.8% |
| Current Assets | $115.9M | -25.0% |
| Total Assets | $134.3M | -19.8% |
| Current Liabilities | $65.2M | +2.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.8M | -1354.8% |
| Capital Expenditures | $450K | -28.2% |
| Investing Cash Flow | $72.8M | +190.9% |
| Financing Cash Flow | $6.5M | -89.5% |
| Free Cash Flow | -$74.2M | -1513.2% |
| -227.0% |
| EPS (Basic) | -$0.34 | -209.1% |
| EPS (Diluted) | -$0.34 | -209.1% |
| Long-term Debt |
| $40.0M |
| +100.0% |
| Total Liabilities | $147.9M | +8.0% |
| Stockholders' Equity | -$13.6M | -144.8% |